ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 85 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $333,000 | +32.1% | 36,113 | +10.6% | 0.06% | -21.3% |
| Q4 2016 | $252,000 | +8.6% | 32,651 | +61.1% | 0.08% | -33.0% |
| Q3 2016 | $232,000 | -7.2% | 20,269 | 0.0% | 0.11% | -39.8% |
| Q2 2016 | $250,000 | +100.0% | 20,269 | +63.9% | 0.19% | +8.1% |
| Q1 2016 | $125,000 | – | 12,369 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 825,647 | $19,238,000 | 3.04% |
| SECTORAL ASSET MANAGEMENT INC | 1,392,485 | $32,445,000 | 1.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 75,000 | $1,748,000 | 0.43% |
| Eventide Asset Management | 52,800 | $1,230,000 | 0.17% |
| Alyeska Investment Group, L.P. | 250,434 | $5,835,000 | 0.13% |
| Convergence Investment Partners, LLC | 28,715 | $669,000 | 0.09% |
| COLUMBUS CIRCLE INVESTORS | 253,348 | $5,903,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 66,800 | $1,557,000 | 0.04% |
| Visium Asset Management, LP | 75,001 | $1,748,000 | 0.03% |
| Hodges Capital Management Inc. | 15,000 | $349,000 | 0.02% |